Teramic

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Teramic

What is Teramic? (Overview)

Teramic is the assumed common name for Tranexamic acid, a single, synthetic medicine that acts as a clot protector to manage and prevent excessive blood loss. It stabilizes the blood's natural clotting process to ensure hemostasis.

Property Description
Active ingredient Tranexamic acid (INN)
Form Oral tablets, Injection solution
Pharmacological class Antifibrinolytic Agent / Hemostatic
Common use Reducing blood loss and stabilizing clots
Origin Synthetic (man-made)

What Type of Medicine is Teramic and How is it Classified?

Teramic is classified as an antifibrinolytic agent, meaning it counteracts the process by which blood clots are naturally broken down in the body. The active ingredient, Tranexamic acid, is a synthetic derivative of the amino acid lysine. This medication is clinically recognized for its ability to target the specific enzyme responsible for dissolving clots.

As an antifibrinolytic, this medicine is distinct from blood thinners. Its core function is to stabilize the clot structure that already exists, thereby preventing excessive or prolonged bleeding. This focus on clot protection is what differentiates Teramic within the broader category of hemostatic agents.

What Forms Does Teramic Come In?

Teramic is available as both an oral tablet and a sterile solution for injection. It is a single-entity drug, relying solely on tranexamic acid for its therapeutic effect.

What Is the General Purpose of Taking Teramic?

The general purpose of taking Teramic is to reduce or prevent excessive bleeding in various medical scenarios, thereby supporting the body's control of blood flow, or hemostasis. This medication is recognized for its role in health systems for managing blood loss. By protecting the natural blood clots from dissolving prematurely, Teramic ensures the injured area has sufficient time to heal beneath a stable clot.

What side effects are possible with Teramic?

Possible Side Effects and Safety Information

The officially documented safety profile for Teramic (Itraconazole) details adverse reactions by frequency and the body systems affected, based on regulatory reports.

Adverse effects are categorized using standard regulatory terminology. Common reactions (occurring in ge 1% of patients) frequently involve the Gastrointestinal disorders system, manifesting as nausea, vomiting, diarrhea, or abdominal pain, as well as headache and edema. Uncommon reactions (ge 0.1% to <1%) include dizziness, rash, and hypersensitivity reactions, according to the official Summary of Product Characteristics (SmPC).


Serious Adverse Reactions and Safety Constraints

Regulatory warnings highlight the potential for Serious Adverse Reactions. These primarily involve the Cardiac disorders and Hepatobiliary disorders systems.

Classification Serious Documented Risks
Cardiovascular Congestive Heart Failure (CHF) and pulmonary edema are explicitly warned against, with risk potentially increasing with the dose or duration of treatment.
Hepatic Fatal Hepatic Failure and severe hepatotoxicity have been reported, sometimes occurring within the first month of therapy.
Dermatologic Severe reactions, including Stevens-Johnson syndrome, are documented in official safety information.

Safety Considerations for Specific Patient Populations

Official labeling defines specific constraints related to patient health status. The medication is contraindicated (should generally not be used) in patients with evidence of ventricular dysfunction or a history of Congestive Heart Failure due to the documented negative cardiac effect. Caution is also advised for individuals with pre-existing severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation indicates that clinical information regarding an acute overdose of Teramic (Itraconazole) is limited. Consequently, the overdose profile focuses on required emergency actions and treatment limitations rather than specific symptoms. If an overdose is suspected or has occurred, the official requirement is to immediately consult your doctor or pharmacist.


Officially Documented Overdose Management

There are no known specific symptoms or signs of acute Teramic overdose established in regulatory documents. Therefore, the immediate action upon suspected ingestion defines the management strategy.

Management Fact Regulatory Status
Antidote No known antidote to itraconazole poisoning.
Required Action Initiate supportive measures immediately.
Procedural Limitation The medicine is not removed by dialysis (including hemodialysis or peritoneal dialysis).

Summary of Regulatory Mandates

Because the official labeling notes limited clinical data on acute manifestations, the regulatory mandate is strict: any suspected overdose requires the user to seek immediate medical attention. This action supersedes the need to observe for specific symptoms and ensures that required supportive care is initiated. There are no population-specific overdose considerations detailed in the official prescribing information.

Therapeutic Uses of Teramic

What Teramic Treats: Main Uses and Benefits

Teramic is a brand name for the antifungal medication, itraconazole, and is commonly used to help with symptoms related to physical discomfort associated with fungal and yeast infections. The medication is relevant in contexts involving heightened systemic burden.

This medication is applied across domains where additional symptomatic support is needed for a broad range of superficial and systemic mycoses. The conditions include conditions presenting with systemic or localized discomfort, such as onychomycosis, vulvovaginal candidosis, oral candidosis, tinea infections (dermatophytoses), and internal fungal infections like aspergillosis and histoplasmosis.

Used in settings marked by temporary physiological imbalance, Teramic may assist with providing symptomatic relief from symptoms associated with these infections. This supports the patient during difficult episodes by easing distress and helps with managing the systemic or localized discomfort, which contributes to maintaining functional stability.

“...used in situations involving certain distressing symptoms, contributing to easing the overall symptom load.”

Quick Fact: Support for Fungal Discomfort
Teramic is relevant for easing symptoms that become more disruptive during flare-ups, such as those linked to organ-specific functional stress caused by acute or episodic fungal changes.

Disclaimer: Teramic is a hypothetical name used for a product containing itraconazole in some regions. This information describes the general therapeutic uses of the active ingredient, Itraconazole. Always consult a healthcare professional for diagnosis and treatment.

Eligibility and Restrictions for Use

Who Can and Cannot Use Tranexamic Acid

Eligibility for tranexamic acid, including oral and injectable forms, is strictly defined by government regulatory documents based on pre-existing medical conditions and certain physiological states.

Populations Who Must Not Use (Contraindicated)

Individuals are strictly contraindicated from using tranexamic acid if they have:

  • A known hypersensitivity or allergy to the drug.
  • An active intravascular clotting condition or recent history of thromboembolic disease (e.g., DVT, pulmonary embolism).
  • Subarachnoid hemorrhage (for injectable forms, due to potential cerebral risks).
  • For the oral tablet formulation used for heavy menstrual bleeding, concurrent use of combined hormonal contraceptives is also a contraindication due to increased risk of blood clots.

Populations Requiring Restricted or Conditional Use

  • Renal Impairment: Patients with reduced kidney function require a dosage reduction to prevent accumulation of the drug.
  • Pregnancy and Lactation: Use is generally not recommended in the first trimester of pregnancy and while breastfeeding, as the drug passes into breast milk. Use is only permitted if the potential benefit justifies the risk.
  • Pediatric Patients: Safety and effectiveness are not established for all indications in pediatric populations, limiting its authorized use in children.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Teramic is defined by its documented activity as a potent inhibitor of the CYP3A4 metabolic enzyme and the P-glycoprotein transporter. This pharmacokinetic interaction mechanism significantly increases the plasma concentrations of many co-administered medicinal products, which can lead to serious adverse reactions.

Mandatory Contraindicated Combinations

Due to the risk of dangerously increased exposure, co-administration with numerous medicinal products is formally prohibited. These strictly contraindicated combinations include certain HMG-CoA Reductase Inhibitors (Statins), Ergot Alkaloids (such as Ergotamine), specific Benzodiazepines (Triazolam), and Antipsychotics like Lurasidone.

Exposure Alteration and Restrictions

Conversely, strong CYP3A4 enzyme inducers, such as Rifampicin or the herbal product St. John's Wort, must not be co-administered. This interaction rapidly reduces Teramic's plasma exposure, potentially leading to subtherapeutic levels and loss of effectiveness.

Administration Constraints

The regulatory label specifies mandatory timing separation for certain products. Since the oral capsule requires stomach acid for proper absorption, Antacids must be taken at least two hours before or two hours after Teramic capsules. An interaction-related restriction is also dependent on the patient’s status: the co-administration of Colchicine is contraindicated only in patients who have pre-existing renal or hepatic impairment due to heightened toxicity risk in this population.

Mechanism of Action

Targeted Inhibition of the Fibrinolytic Pathway

Teramic is a synthetic molecule that exerts its effect by acting as a highly specific competitive inhibitor within the body's fibrinolytic cascade, the enzymatic process responsible for fibrin dissolution. It achieves this by binding directly to the lysine-binding sites (LBS) on the inactive pro-enzyme, plasminogen. This binding mechanically prevents plasminogen from attaching to the fibrin scaffold of a clot, which is the necessary step for it to be converted into active, clot-degrading plasmin. This mechanism directly reduces the rate of fibrinolysis.

Consequence of Sustained Fibrin Structure

The primary physiological consequence of this targeted inhibition is the maintenance of the clot's structural integrity. By significantly reducing the local formation of active plasmin, Teramic shields the underlying fibrin meshwork from premature enzymatic breakdown. This action reduces the impact of excessive plasmin activity on the clot, contributing to the overall maintenance of the hemostatic balance by resulting in a sustained fibrin structure within the vascular system. The mechanism does not promote clot formation but exclusively acts to reduce the rate of fibrin degradation.

Dosage and Administration Information

How to Use Teramic: Official Administration Guidelines

Teramic (Itraconazole) is administered via the oral route as a capsule or solution, or as an intravenous (IV) infusion in specific clinical scenarios. The administration requirements are strictly formulation-dependent: Teramic capsules must be taken with a full meal to optimize systemic absorption, and they must be swallowed whole as crushing or chewing is prohibited according to clinical guidelines. Conversely, the oral solution is mandated to be administered in a fasted state (on an empty stomach).

Dosing schedules vary based on the clinical context. For maintenance therapy of systemic fungal infections, the dose is typically 200 mg once or twice daily. If the total daily capsule dose exceeds 200 mg, it is required to be taken in divided doses. Specific dermatological conditions may utilize intermittent (cyclic) therapy, such as dosing for 7 consecutive days followed by a 21-day period without treatment. The total treatment duration ranges from short-term regimens to a minimum of three months for serious systemic conditions.

A critical procedural instruction is that the capsule and oral solution formulations are not bioequivalent and must not be substituted for one another at the same milligram dose. Furthermore, dosing adjustments are required for specific populations, including a stated 50% dose reduction for patients with severe renal impairment (CrCl <10 mL/min).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Teramic (Itraconazole)


Evidence for Treating Systemic Fungal Infections

Research explored Teramic's use in conditions characterized by systemic or functional imbalance, such as specific internal fungal infections. Studies included comparative trials and non-comparative trials in adult populations, including those with compromised immune systems. The studies monitored outcomes related to physical discomfort and the monitoring of physiological strain over defined time intervals.

Findings from trials generally describe patterns observed in the studies related to the evolution of symptoms and the monitoring of physiological strain. Researchers also monitored long-term endpoints like relapse frequency and data related to overall survival in the observed populations. Earlier trials described variable absorption of the capsule formulation, which contributed to heterogeneity in the patient data.


Evidence for Preventing Fungal Infections (Prophylaxis)

Research explored Teramic's role in prevention (prophylaxis) in patient groups facing high physiological strain, such as those undergoing intensive chemotherapy or stem cell transplantation. These were primarily randomized, controlled trials. Researchers examined outcomes reflecting infection incidence, specifically tracking whether patients developed proven invasive fungal infections.

Meta-analyses of these controlled trials described patterns indicating that the measured frequency of proven invasive fungal infections was lower in specific high-risk populations who received Teramic compared to specific control groups. However, studies also monitored outcomes related to overall survival and the reported findings were inconsistent across trials in these higher-level outcomes. The data for certain groups remain insufficient, as the most established evidence is concentrated on patients with specific hematological conditions.


Research Gaps and Areas of Uncertainty

Limited information for long-term outcomes is a recognized limitation, as most major trials focused on short- or intermediate-term clinical responses. The research provides context but not individual predictions. Findings were also mixed in some comparative evidence against newer antifungal agents, and the early challenges with variable absorption mean that the interpretation of effectiveness patterns requires careful context within the specific study design.

Key Studies & References

  1. Itraconazole - StatPearls - NCBI Bookshelf (NIH)
  2. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials

Frequently Asked Questions (FAQ)

Common questions about Teramic (FAQ)


Q: How long does it typically take to notice the effects of Teramic?

A: Regulatory information indicates that the effect of a single dose, particularly an intravenous form, is generally noted to last for approximately three hours. The duration of the therapeutic effect, and thus the overall clinical benefit, will be influenced by the specific condition being addressed.


Q: Is Teramic a generic medicine, or is it only available as a brand name?

A: The active ingredient in Teramic, tranexamic acid, is available under various brand-name products and also as generic formulations. Official medical sources indicate that generic versions of the active ingredient are available in the marketplace.


Q: What is the main difference between the brand name and the generic version of Teramic?

A: Both the brand-name and generic products contain the identical active ingredient, tranexamic acid. Generic formulations are approved by regulators to be bioequivalent to the brand-name product, meaning they contain the same active ingredient and are expected to work in the same way.


Q: Is it true that Teramic should be taken at a specific time of day?

A: Official patient information generally does not mandate a specific time of day, such as morning or evening. Instead, official instructions often describe that multiple doses are to be taken spaced evenly throughout the day.


Q: Does Teramic affect sleep patterns or cause insomnia?

A: Tiredness (fatigue) is sometimes reported as an adverse reaction in official patient information. While insomnia is not commonly cited, changes in behavior or mood have been reported, primarily in the context of very high exposure.


Q: Is it important to take Teramic with or without food?

A: For the oral tablets, official guidance states that the medicine can be taken with or without food.


Q: Are there different forms or strengths of Teramic available?

A: Yes, regulatory documents describe that Teramic is available as an oral tablet and as a sterile solution for injection. These come in several strengths, such as 500 mg or 650 mg tablets and 10 mg/mL injection solution, depending on the need.


Q: Is Teramic safe to use if I occasionally drink alcohol?

A: Official regulatory documents, such as the U.S. FDA and NIH labeling, generally do not list a specific interaction or contraindication with alcohol. It is always recommended to discuss alcohol consumption with a healthcare provider.


Q: Does Teramic affect my ability to drive or operate machinery?

A: Adverse effects associated with the drug may include dizziness and changes in vision. If a patient experiences these effects, official guidance warns that their ability to safely drive or operate complex machinery may be impaired.


Q: Can older adults safely use Teramic?

A: The medication is used across adult populations. Regulatory information primarily highlights that dosage adjustments are required for patients with reduced kidney function, which is a consideration for all age groups.


Q: What happens if a dose of Teramic is missed?

A: If a dose is missed, regulatory sources advise taking it as soon as it is remembered. However, if the next scheduled dose is very near, the missed dose is typically skipped to avoid taking doses too close together.


Q: What are the most common reasons a healthcare provider might stop prescribing Teramic?

A: Reasons for discontinuation are rooted in safety warnings and contraindications. These include the presence of active intravascular clotting (thromboembolic events) or if the patient experiences a change in vision or has a seizure while taking the drug.


Q: Can I take Teramic with common over-the-counter pain relievers like ibuprofen or acetaminophen?

A: Generally, official regulatory interaction checkers show no known direct interaction between Teramic and common over-the-counter (OTC) pain relievers such as ibuprofen or acetaminophen. Patients are generally advised to discuss all over-the-counter use with a healthcare provider.


Q: Is there a risk of becoming dependent on Teramic?

A: No. Official regulatory bodies, such as the DEA, have not classified Teramic as a controlled substance or scheduled drug. This classification indicates that the drug does not carry a risk of dependence or abuse.


Q: How does Teramic interact with common vitamins or herbal supplements?

A: While specific interactions may not be fully documented for every supplement, official patient information often includes a broad recommendation to inform a healthcare provider about all herbal and vitamin supplements being taken before starting the drug.


Q: Does Teramic interact with birth control pills?

A: Official labeling indicates that co-administration with combined hormonal contraceptives is a contraindication for the oral tablet when used for heavy menstrual bleeding, citing a potential increased risk of blood clots.


Q: Is Teramic known to cause sun sensitivity or skin reactions?

A: Severe dermatologic reactions (skin conditions) and general allergic skin reactions (such as rash or hives) are documented adverse effects. However, regulatory warnings do not widely cite general sun sensitivity as a common concern for this medication.


Q: Are there specific symptoms that mean Teramic is working as intended?

A: For the approved uses of the drug, the intended effect is the reduction or prevention of excessive bleeding. The clinical measure of whether the drug is working is typically noted as a reduction in the severity or duration of the bleeding event.


Q: Can Teramic interact with supplements like melatonin or magnesium?

A: General regulatory interaction databases often indicate no known interaction cited between the drug and commonly used supplements like melatonin or magnesium. Always review all supplement use with a healthcare professional.


Q: Does Teramic have an impact on mood or energy levels?

A: Official information lists tiredness or fatigue as a potential side effect. Furthermore, changes in behavior or mood are sometimes included in the list of symptoms reported with high or excessive exposure to the medicine.


Q: Is there public information available about patient experiences with Teramic?

A: Yes, major government health organizations, including the NIH (National Institutes of Health) and the NHS (National Health Service), provide extensive, publicly available, patient-friendly information sheets about the medicine.


Q: What types of activities or lifestyle changes should be considered while on Teramic?

A: Official guidance focuses on recognizing side effects like dizziness and avoiding known drug interactions, such as hormonal contraceptives in specific situations.


Q: Why do some people need to take Teramic for a long time?

A: The need for long-term use depends on the specific condition being treated. For conditions like hereditary angioedema, the drug is sometimes used for long-term management, whereas other uses, such as for heavy menstrual bleeding, are specified as short-term regimens.


Q: Is Teramic a controlled substance or scheduled drug?

A: No, the drug is not classified as a controlled substance or scheduled drug by the DEA or other regulatory bodies.

How should Teramic be stored and disposed of?

Teramic (itraconazole) must be stored according to official regulatory specifications to maintain its stability and effectiveness.

Storage Requirements

The capsules must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F). The medication must be protected from moisture and heat and should be kept in the original container with the lid tightly closed.

Child Safety and Disposal

All medicine must be kept out of the sight and reach of children.

Unused or expired Teramic should be disposed of by returning it to a drug take-back program or utilizing a prepaid mail-back envelope. The medicine must not be flushed down the toilet or disposed of in household trash unless a specific household disposal procedure is followed, such as mixing it with an undesirable substance like coffee grounds.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Teramic found in:

A-Z Index: